This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coté, C. J.
Right arrow Articles by McCloskey, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coté, C. J.
Right arrow Articles by McCloskey, C.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 106 No. 4 October 2000, pp. 633-644

Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation

Received Jan 11, 2000; accepted Jun 22, 2000.

Charles J. Coté*, Helen W. KarlDagger , Daniel A. Notterman§, Joseph A. Weinbergparallel , and Carolyn McCloskey

From the * Department of Pediatric Anesthesiology, Children's Memorial Hospital, Northwestern University School of Medicine, Chicago, Illinois; Dagger  Department of Pediatric Anesthesiology, Children's Hospital, University of Washington School of Medicine, Seattle, Washington; § Department of Molecular Biology, Princeton University, Princeton, New Jersey and the Division of Critical Care Medicine, New York Presbyterian Hospital, New York, New York; parallel  Department of Emergency Services, LeBonheur Children's Medical Center and the Department of Pediatrics, University of Tennessee College of Medicine, Memphis Tennessee; and the  Food and Drug Administration, Center for Drug Evaluation and Research, Office of Post-Marketing Drug Risk Assessment, Division of Drug Risk Evaluation II, Washington, DC.

Objectives.  To perform a systematic investigation of medications associated with adverse sedation events in pediatric patients using critical incident analysis of case reports.

Methods.  One hundred eighteen case reports from the adverse drug reporting system of the Food and Drug Administration, the US Pharmacopoeia, and the results of a survey of pediatric specialists were used. Outcome measures were death, permanent neurologic injury, prolonged hospitalization without injury, and no harm. The overall results of the critical incident analysis are reported elsewhere. The current investigation specifically examined the relationship between outcome and medications: individual and classes of drugs, routes of administration, drug combinations and interactions, medication errors and overdoses, patterns of drug use, practitioners, and venues of sedation.

Results.  Ninety-five incidents fulfilled study criteria and all 4 reviewers agreed on causation; 60 resulted in death or permanent neurologic injury. Review of adverse sedation events indicated that there was no relationship between outcome and drug class (opioids; benzodiazepines; barbiturates; sedatives; antihistamines; and local, intravenous, or inhalation anesthetics) or route of administration (oral, rectal, nasal, intramuscular, intravenous, local infiltration, and inhalation). Negative outcomes (death and permanent neurologic injury) were often associated with drug overdose (n = 28). Some drug overdoses were attributable to prescription/transcription errors, although none of 39 overdoses in 34 patients seemed to be a decimal point error. Negative outcomes were also associated with drug combinations and interactions. The use of 3 or more sedating medications compared with 1 or 2 medications was strongly associated with adverse outcomes (18/20 vs 7/70). Nitrous oxide in combination with any other class of sedating medication was frequently associated with adverse outcomes (9/10). Dental specialists had the greatest frequency of negative outcomes associated with the use of 3 or more sedating medications. Adverse events occurred despite drugs being administered within acceptable dosing limits. Negative outcomes were also associated with drugs administered by nonmedically trained personnel and drugs administered at home. Some injuries occurred on the way to a facility after administration of sedatives at home; some took place in automobiles or at home after discharge from medical supervision. Deaths and injuries after discharge from medical supervision were associated with the use of medications with long half-lives (chloral hydrate, pentobarbital, promazine, promethazine, and chlorpromazine).

Conclusions.  Adverse sedation events were frequently associated with drug overdoses and drug interactions, particularly when 3 or more drugs were used. Adverse outcome was associated with all routes of drug administration and all classes of medication, even those (such as chloral hydrate) thought to have minimal effect on respiration. Patients receiving medications with long plasma half-lives may benefit from a prolonged period of postsedation observation. Adverse events occurred when sedative medications were administered outside the safety net of medical supervision. Uniform monitoring and training standards should be instituted regardless of the subspecialty or venue of practice. Standards of care, scope of practice, resource management, and reimbursement for sedation should be based on the depth of sedation achieved (ie, the degree of vigilance and resuscitation skills required) rather than on the drug class, route of drug administration, practitioner, or venue.  Key words:  sedation, adverse events, critical incident, medication errors, monitoring, guidelines, procedures, systems errors, drug overdose, drug-drug interactions, critical incident analysis.




This article has been cited by other articles:


Home page
 Br J AnaesthHome page
A.-M. Machata, H. Willschke, B. Kabon, S. C. Kettner, and P. Marhofer
Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging
Br. J. Anaesth., August 1, 2008; 101(2): 239 - 243.
[Abstract] [Full Text] [PDF]

Home page
 EDUCATION AND PRACTICEHome page
A. J Harvey and N. S Morton
Management of procedural pain in children
Arch. Dis. Child. Ed. Pract., February 1, 2007; 92(1): ep20 - ep26.
[Full Text] [PDF]

Home page
 PediatricsHome page
American Academy of Pediatrics, American Academy of Pediatric Dentistry, C. J. Cote, S. Wilson, and the Work Group on Sedation
Guidelines for Monitoring and Management of Pediatric Patients During and After Sedation for Diagnostic and Therapeutic Procedures: An Update
Pediatrics, December 1, 2006; 118(6): 2587 - 2602.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. G. Dalal, D. Murray, T. Cox, J. McAllister, and R. Snider
Sedation and Anesthesia Protocols Used for Magnetic Resonance Imaging Studies in Infants: Provider and Pharmacologic Considerations
Anesth. Analg., October 1, 2006; 103(4): 863 - 868.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. P. Cravero, G. T. Blike, M. Beach, S. M. Gallagher, J. H. Hertzog, J. E. Havidich, B. Gelman, and and the Pediatric Sedation Research Consortium
Incidence and Nature of Adverse Events During Pediatric Sedation/Anesthesia for Procedures Outside the Operating Room: Report From the Pediatric Sedation Research Consortium
Pediatrics, September 1, 2006; 118(3): 1087 - 1096.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
F E Babl, J Munro, G Kainey, G M Palmer, and A Iser
Scope for improvement: hospital wide sedation practice at a children's hospital.
Arch. Dis. Child., August 1, 2006; 91(8): 716 - 717.
[Full Text] [PDF]

Home page
 PediatricsHome page
L. C. Heistein, C. Ramaciotti, W. A. Scott, M. Coursey, P. W. Sheeran, and M. S. Lemler
Chloral Hydrate Sedation for Pediatric Echocardiography: Physiologic Responses, Adverse Events, and Risk Factors
Pediatrics, March 1, 2006; 117(3): e434 - e441.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Malviya, T. Voepel-Lewis, and A. R. Tait
A Comparison of Observational and Objective Measures to Differentiate Depth of Sedation in Children from Birth to 18 Years of Age
Anesth. Analg., February 1, 2006; 102(2): 389 - 394.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. A. Sanborn, E. Michna, D. Zurakowski, P. E. Burrows, P. J. Fontaine, L. Connor, and K. P. Mason
Adverse Cardiovascular and Respiratory Events during Sedation of Pediatric Patients for Imaging Examinations
Radiology, October 1, 2005; 237(1): 288 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
K E Walsh, R Kaushal, and J B Chessare
How to avoid paediatric medication errors: a user's guide to the literature
Arch. Dis. Child., July 1, 2005; 90(7): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. R. Starke, J. Weaver, and B. A. Chowdhury
Boxed Warning Added to Promethazine Labeling for Pediatric Use
N. Engl. J. Med., June 23, 2005; 352(25): 2653 - 2653.
[Full Text] [PDF]

Home page
 J Child NeurolHome page
T. Kagan-Kushnir, S. W. Roberts, and O. C. Snead
Screening Electroencephalograms in Autism Spectrum Disorders: Evidence-Based Guideline
J Child Neurol, March 1, 2005; 20(3): 197 - 206.
[Abstract] [PDF]

Home page
 RadiologyHome page
K. P. Mason, D. Zurakowski, L. Connor, V. E. Karian, P. J. Fontaine, P. A. Sanborn, and P. E. Burrows
Infant Sedation for MR Imaging and CT: Oral versus Intravenous Pentobarbital
Radiology, December 1, 2004; 233(3): 723 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. P. Cravero and G. T. Blike
Review of Pediatric Sedation
Anesth. Analg., November 1, 2004; 99(5): 1355 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
E. Trevathan
Seizures and Epilepsy Among Children With Language Regression and Autistic Spectrum Disorders
J Child Neurol, August 1, 2004; 19(1_suppl): S49 - S57.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
E. Trevathan
Seizures and Epilepsy Among Children With Language Regression and Autistic Spectrum Disorders
J Child Neurol, January 1, 2004; 19(1_suppl): S49 - S57.
[Abstract] [PDF]

Home page
 AAP NewsHome page
C. J. Cote
Pediatric, dental communities concerned about safe sedation for kids
AAP News, October 1, 2002; 21(4): 204 - 204.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Drugs
Guidelines for Monitoring and Management of Pediatric Patients During and After Sedation for Diagnostic and Therapeutic Procedures: Addendum
Pediatrics, October 1, 2002; 110(4): 836 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
C. J. Cote
Sedation disasters in pediatrics and concerns for office based practice
Can J Anesth, June 1, 2002; 49(90001): R10 - 10.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
J. Laham
Propofol: Risk vs. Benefit
Clinical Pediatrics, January 1, 2002; 41(1): 5 - 7.
[PDF]

Home page
 Anesth. Analg.Home page
C. J. Cote, I. T. Cohen, S. Suresh, M. Rabb, J. B. Rose, B. C. Weldon, P. J. Davis, G. B. Bikhazi, H. W. Karl, K. A. Hummer, et al.
A Comparison of Three Doses of a Commercially Prepared Oral Midazolam Syrup in Children
Anesth. Analg., January 1, 2002; 94(1): 37 - 43.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. J. Cote
Sedation for Electroencephalograms
Pediatrics, October 1, 2001; 108(4): 1053 - 1054.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. Malviya, A. R. Tait, T. Voepel-Lewis, L. G. Maxwell;, C. J. Cote;, and J. M. Freeman
Oranges and Apples: Sedation and Analgesia
Pediatrics, September 1, 2001; 108(3): 824 - 824.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Freeman
The Risks of Sedation for Electroencephalograms: Data at Last
Pediatrics, July 1, 2001; 108(1): 178 - 178.
[Full Text]